- call +1-201-465-4211
- email sales@mrinsights.biz
Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are most common on the back. Sometimes they develop from a mole with changes such as an increase in size, irregular edges, change in color, itchiness, or skin breakdown.
Scope of the Report:
This report studies the Melanoma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Melanoma market by product type and applications/end industries.
Confirmation of the clinical diagnosis is done with a skin biopsy. It is usually followed up with a wider excision of the scar or tumor. Depending on the stage, a sentinel lymph node biopsy may be performed. Treatment of advanced malignant melanoma is performed from a multidisciplinary approach.
The global Melanoma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Melanoma.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Amgen
Eristol-Mayers Squibb
Eisai
Roche
Genetech
Janssen Biotech
Pfizer
Novartis
Vical
Ziopharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Superficial Melanoma
Nodular Melanoma
Lentigo Maglina Melanoma
Acral Lentigious
Market Segment by Applications, can be divided into
Hospitals
Pharmaceutical Companies
Research Centres
Clinics
Laboratories
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Melanoma Market Overview
1.1 Product Overview and Scope of Melanoma
1.2 Classification of Melanoma by Types
1.2.1 Global Melanoma Revenue Comparison by Types (2017-2023)
1.2.2 Global Melanoma Revenue Market Share by Types in 2017
1.2.3 Superficial Melanoma
1.2.4 Nodular Melanoma
1.2.5 Lentigo Maglina Melanoma
1.2.6 Acral Lentigious
1.3 Global Melanoma Market by Application
1.3.1 Global Melanoma Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Research Centres
1.3.5 Clinics
1.3.6 Laboratories
1.4 Global Melanoma Market by Regions
1.4.1 Global Melanoma Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Melanoma Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Melanoma Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Melanoma Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Melanoma Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Melanoma Status and Prospect (2013-2023)
1.5 Global Market Size of Melanoma (2013-2023)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Melanoma Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eristol-Mayers Squibb
2.2.1 Business Overview
2.2.2 Melanoma Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eristol-Mayers Squibb Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eisai
2.3.1 Business Overview
2.3.2 Melanoma Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eisai Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Melanoma Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.5 Genetech
2.5.1 Business Overview
2.5.2 Melanoma Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Genetech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.6 Janssen Biotech
2.6.1 Business Overview
2.6.2 Melanoma Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Janssen Biotech Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Melanoma Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Melanoma Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.9 Vical
2.9.1 Business Overview
2.9.2 Melanoma Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Vical Melanoma Revenue, Gross Margin and Market Share (2016-2017)
2.10 Ziopharm
2.10.1 Business Overview
2.10.2 Melanoma Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ziopharm Melanoma Revenue, Gross Margin and Market Share (2016-2017)
3 Global Melanoma Market Competition, by Players
3.1 Global Melanoma Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Melanoma Players Market Share
3.2.2 Top 10 Melanoma Players Market Share
3.3 Market Competition Trend
4 Global Melanoma Market Size by Regions
4.1 Global Melanoma Revenue and Market Share by Regions
4.2 North America Melanoma Revenue and Growth Rate (2013-2018)
4.3 Europe Melanoma Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Melanoma Revenue and Growth Rate (2013-2018)
4.5 South America Melanoma Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Melanoma Revenue and Growth Rate (2013-2018)
5 North America Melanoma Revenue by Countries
5.1 North America Melanoma Revenue by Countries (2013-2018)
5.2 USA Melanoma Revenue and Growth Rate (2013-2018)
5.3 Canada Melanoma Revenue and Growth Rate (2013-2018)
5.4 Mexico Melanoma Revenue and Growth Rate (2013-2018)
6 Europe Melanoma Revenue by Countries
6.1 Europe Melanoma Revenue by Countries (2013-2018)
6.2 Germany Melanoma Revenue and Growth Rate (2013-2018)
6.3 UK Melanoma Revenue and Growth Rate (2013-2018)
6.4 France Melanoma Revenue and Growth Rate (2013-2018)
6.5 Russia Melanoma Revenue and Growth Rate (2013-2018)
6.6 Italy Melanoma Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Melanoma Revenue by Countries
7.1 Asia-Pacific Melanoma Revenue by Countries (2013-2018)
7.2 China Melanoma Revenue and Growth Rate (2013-2018)
7.3 Japan Melanoma Revenue and Growth Rate (2013-2018)
7.4 Korea Melanoma Revenue and Growth Rate (2013-2018)
7.5 India Melanoma Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Melanoma Revenue and Growth Rate (2013-2018)
8 South America Melanoma Revenue by Countries
8.1 South America Melanoma Revenue by Countries (2013-2018)
8.2 Brazil Melanoma Revenue and Growth Rate (2013-2018)
8.3 Argentina Melanoma Revenue and Growth Rate (2013-2018)
8.4 Colombia Melanoma Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Melanoma by Countries
9.1 Middle East and Africa Melanoma Revenue by Countries (2013-2018)
9.2 Saudi Arabia Melanoma Revenue and Growth Rate (2013-2018)
9.3 UAE Melanoma Revenue and Growth Rate (2013-2018)
9.4 Egypt Melanoma Revenue and Growth Rate (2013-2018)
9.5 Nigeria Melanoma Revenue and Growth Rate (2013-2018)
9.6 South Africa Melanoma Revenue and Growth Rate (2013-2018)
10 Global Melanoma Market Segment by Type
10.1 Global Melanoma Revenue and Market Share by Type (2013-2018)
10.2 Global Melanoma Market Forecast by Type (2018-2023)
10.3 Superficial Melanoma Revenue Growth Rate (2013-2023)
10.4 Nodular Melanoma Revenue Growth Rate (2013-2023)
10.5 Lentigo Maglina Melanoma Revenue Growth Rate (2013-2023)
10.6 Acral Lentigious Revenue Growth Rate (2013-2023)
11 Global Melanoma Market Segment by Application
11.1 Global Melanoma Revenue Market Share by Application (2013-2018)
11.2 Melanoma Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Pharmaceutical Companies Revenue Growth (2013-2018)
11.5 Research Centres Revenue Growth (2013-2018)
11.6 Clinics Revenue Growth (2013-2018)
11.7 Laboratories Revenue Growth (2013-2018)
12 Global Melanoma Market Size Forecast (2018-2023)
12.1 Global Melanoma Market Size Forecast (2018-2023)
12.2 Global Melanoma Market Forecast by Regions (2018-2023)
12.3 North America Melanoma Revenue Market Forecast (2018-2023)
12.4 Europe Melanoma Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Melanoma Revenue Market Forecast (2018-2023)
12.6 South America Melanoma Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Melanoma Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Melanoma Picture
Table Product Specifications of Melanoma
Table Global Melanoma and Revenue (Million USD) Market Split by Product Type
Figure Global Mel
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
